Award

The Importance of Adipokines in Mediating the Relationship of Obesity with Cardiometabolic Disease: Implications for HF

Description: Obesity is a major public health challenge, affecting over 90 million adults in the U.S. Obesity is linked to myriad health consequences, including the development of insulin resistance and the related cardiometabolic risk factors comprising the metabolic syndrome, and diabetes, which predispose to an increased likelihood of cardiovascular disease (CVD) and particularly heart failure. Studies have demonstrated that up to 40% of individuals with obesity do not have overt metabolic abnormalities, a group referred to as having "metabolically healthy" obesity (MHO). However, it is unclear whether MHO is a benign condition, as MHO may be linked to adverse outcomes with long-term follow-up and many individuals transition from MHO to "metabolically unhealthy" obesity (MUO) with aging. There is great interest in understanding the pathways underlying the transition from MHO to MUO. A potentially important mediator of metabolic abnormalities in obesity may be adipokines, a group of pro- and anti-inflammatory proteins secreted by adipocytes and surrounding inflammatory cells. In complementary basic science and population/clinical projects, the proposed Center will evaluate the link of adipokines with transitions from metabolically healthy to unhealthy obesity over time. The basic project will utilize pro- and anti-inflammatory adopkine mouse models and the population poject adipookine trajectoris. We will also evaluate the effects of adipokine and metabolic trajectories on myocardial dysfunction, with both projects focusing on mitochondrial dysfunction as a potential mediator. The basic science project will use NMR spectroscopy to assess energetics and evaluate the role of Dexras1. The populaion project will assess mitochondrial DNA copy number as a potential mediator. The population project will further examine benefits of weight loss, using cardiac biomarkers in a bariatric surgery cohort, and the extent to which benefits are explained by changes in adipokines and metabolic risk factors. This will provide novel insights to inform risk prediction and prevention linked to poor cardiometabolic health.
Amount: $661,100
Funding type: research
Funder scheme: Strategically Focused Research Network
Start date: 2020-01-01
End date: 2023-12-31
Investigator: Chiadi Ndumele (lead)
Institutions: Johns Hopkins University, Johns Hopkins University JHURA
Field: Medicine
Funded outputs count: 16
Funder award ID: 20SFRN35120152
OpenAlex ID: G1933859835
2024 · Eric K. Broni, Justin B. Echouffo-Tcheugui, et al. · American Journal of Obstetrics and Gynecology · 14
2023 · Shivani Misra, Robert Wagner, et al. · Communications Medicine · 152
2023 · Scott Mu, Justin B Echouffo-Tcheugui, et al. · The Journal of Applied Laboratory Medicine · 30
2023 · Eric K. Broni, Oluseye Ogunmoroti, et al. · Endocrine Practice · 6
2023 · Eric K. Broni, Oluseye Ogunmoroti, et al. · Journal of Thrombosis and Haemostasis · 13
2023 · Bhavya Varma, Oluseye Ogunmoroti, et al. · Frontiers in Cardiovascular Medicine · 10
2022 · Justin B. Echouffo-Tcheugui, Natalie Daya, et al. · Diabetologia · 35
2022 · Eric K. Broni, Chiadi E. Ndumele, et al. · Current Diabetes Reports · 35
2021 · Bhavya Varma, Oluseye Ogunmoroti, et al. · Diabetes Epidemiology and Management · 21
2021 · Justin B. Echouffo-Tcheugui, Sui Zhang, et al. · JACC Heart Failure · 82